EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
39 hedge funds and large institutions have $89.8M invested in ESSA Pharma in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
10% less call options, than puts
Call options by funds: $96K | Put options by funds: $107K
40% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 10
Holders
39
Holding in Top 10
–
Calls
$96K
Puts
$107K
Top Buyers
| 1 | +$2.07M | |
| 2 | +$374K | |
| 3 | +$154K | |
| 4 |
Millennium Management
New York
|
+$135K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$134K |
Top Sellers
| 1 | -$746K | |
| 2 | -$703K | |
| 3 | -$638K | |
| 4 |
Two Sigma Advisers
New York
|
-$382K |
| 5 |
CIBC World Market
Toronto,
Ontario, Canada
|
-$130K |